Australia

U.S. Food & Drug Administration (FDA) Approves Investigational New Drug (IND) Application for Myrio's Lead Product (PHOX2B PC-CAR T) for the Treatment of Neuroblastoma

MELBOURNE, Australia, June 13, 2025 /PRNewswire/ -- On 7 May 2025, the FDA approved an IND application enabling Myrio's lead product (PHOX2B PC-CAR T) to enter human trials. Myrio, in collaboration the leading children's hospital in Philadelphia have co-developed a Chimeric Antigen Receptor (CAR-T...

2025-06-13 19:35 1982

Dazu Rock Carvings: The Last Monument of World Grotto Art

CHONGQING, China, June 12, 2025 /PRNewswire/ -- Located in southwest China's Chongqing Municipality, the Dazu Rock Carvings have held UNESCO World Heritage status since 1999. Sprawled across 75 recognized cultural relics protection zones, the site shelters over 50,000 breathtaking statues. As one...

2025-06-12 23:29 1937

Cam Model Earned Over $3.4 Million Streaming on LiveJasmin -- 3rd Edition of International Cam Model Day Celebrates a New Era of Creator Careers

LiveJasmin marks model appreciation week and 25 years in the industry with new opportunities to empower models onwww.cammodelday.com LUXEMBOURG, June 11, 2025 /PRNewswire/ -- A model earning over $3.4 million in a year from behind a screen might sound like a headli...

2025-06-12 01:09 1964

Uzbekistan Sees Foreign Investment Growth of over 60 per cent in 2024

'New Uzbekistan: The Big Country With Big Opportunities – Reform In Action' FDI Report unveiled as Tashkent International Investment Forum Gets Underway TASHKENT, Uzbekistan, June 10, 2025 /PRNewswire/ -- Foreign investment in Uzbekistan is growing rapidly as the country saw an over 60 per cent ...

2025-06-10 17:00 2248

DISCO topline results: 64Cu-SARTATE is highly effective in detecting tumours in NET patients compared to SOC imaging. Phase III planning underway.

HIGHLIGHTS * Topline data from Clarity's diagnostic Phase II trial, DISCO, confirms that 64Cu-SARTATE is safe and highly effective compared to standard-of-care (SOC) imaging at detecting lesions in patients with neuroendocrine tumours (NETs). * DISCO compared the diagnostic performance of 64C...

2025-06-05 21:01 2347

Mérieux NutriSciences and AsureQuality Announce the Official Launch of Mérieux NutriSciences AQ (MNAQ) Joint Venture

CHICAGO and AUCKLAND, New Zealand, June 2, 2025 /PRNewswire/ -- Mérieux NutriSciences, a global leader in food safety, quality, and sustainability, and AsureQuality,New Zealand's premier food assurance provider, are pleased to announce the official launch of their joint venture,Mérieux NutriScien...

2025-06-02 05:00 2694

NEW THERAPY FOR CHILDREN WITH GROWTH HORMONE DEFICIENCY APPROVED IN AUSTRALIA

SKYTROFA® (lonapegsomatropin) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of paediatric growth hormone deficiency.[ 1] SINGAPORE, May 29, 2025 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce the Austr...

2025-05-30 00:01 2183

First patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CT

SYDNEY, May 29, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that it has imaged the...

2025-05-29 21:04 1890

Platinum Jets Officially Launches Services and Real-Time Instant Quote Tool for Private Jet Travel

SWANAGE, England, May 27, 2025 /PRNewswire/ -- Platinum Jets, a boutique private jet charter broker serving a global clientele of business leaders and luxury travelers, is proud to announce the official launch of its services along with the debut of its cutting-edgeInstant Quote feature on 

2025-05-27 21:00 1685

Alma Unveils Alma IQ at Eighth Global Alma Academy in Dubrovnik

The next-generation skin analysis platform, set to redefine the aesthetic consultation experience CAESAREA, Israel, May 27, 2025 /PRNewswire/ -- Alma , a Sisram Medical company and a global leader in energy-based medical and aesthetic solutions, has officially launchedA...

2025-05-27 13:00 1992

Registrational Phase III AMPLIFY trial in biochemical recurrence of prostate cancer commences

SYDNEY, May 20, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that it has commenced ...

2025-05-20 21:02 2014

Klein Vision unveils production prototype of the AirCar

The AirCar will be the world's first mass-produced flying car. BEVERLY HILLS, Calif., May 8, 2025 /PRNewswire/ -- Klein Vision

2025-05-08 15:00 2379

Rishabh Software and S4G Consulting Launch SR360 to Accelerate Digital Transformation in Australia

MELBOURNE, Australia, May 8, 2025 /PRNewswire/ -- Rishabh Software and S4G Consulting have teamed up to introduceSR360 , a business-driven end-to-end Technology service designed to help enterprises moder...

2025-05-08 08:30 2196

Bellroy, the popular Australian carry brand, releases much-anticipated luggage styles

The brand renowned for solving carry problems extends their expertise to travel, with two wheeled carry-on bags that are lightweight, hard-wearing and repairable in under 10 minutes. MELBOURNE, Australia, May 6, 2025 /PRNewswire/ -- Solving problems is in Bellroy's DNA. Since their origin in 201...

2025-05-07 07:10 2091

Blinq Raises $25M Series A to Reimagine the Start of Every Professional Relationship

With over 2.5 million users across 500,000 companies in 189 countries, Blinq is scaling the platform that powers first impressions - and everything after. The new funding will support global expansion, particularly acrossNorth America and Europe, and accelerate Blinq's roadmap to become the conne...

2025-05-07 06:34 2158

Sigenergy Becomes Australia's Top Battery Brand by Market Share, SunWiz Reports

SYDNEY, April 28, 2025 /PRNewswire/ -- Sigenergy, a leading energy innovator, was ranked the No. 1 battery manufacturer inAustralia by blended capacity[1] for the month ofMarch 2025, according to the latest report from SunWiz, an independent expert solar consultancy. Based on kilowatt-hours (kWh)...

2025-04-28 12:27 2189

FDA Grants Authorisation for Minder®, the First and Only Implantable Continuous EEG Monitor Approved in US

*  The Australian-developed Minder system is an implantable device for continuous monitoring of brain activity in patients with epilepsy, developed to address the shortcomings in current electroencephalogram technologies *  The FDA has granted authorisation for Minder under its De Novo pathway...

2025-04-23 06:15 1853

Clarity signs high-volume commercial-scale copper-64 Supply Agreement with Nusano

Highlights * Clarity has signed a commercial-scale agreement with Nusano, Inc. ("Nusano") for supply of copper-64 (Cu-64 or64Cu) isotope. * The 190,000 square foot Nusano facility in West Valley City, Utah is capable of producing more than 1,000 Ci (37,000 GBq) of copper-64 per day at capaci...

2025-04-17 21:01 2849

SECuRE trial update: First patient treated in the Phase II Cohort Expansion

HIGHLIGHTS * The first of the planned 24 participants in the Cohort Expansion Phase (Phase II) of the SECuRE trial has been treated with their first dose of 8 GBq of67Cu-SAR-bisPSMA.This follows the recent recommendation by the Safety Review Committee (SRC) after the successful completion of t...

2025-04-15 21:02 2167

CUBE LAUNCHES REGPLATFORM™ INTEL TO TRANSFORM THE MID-MARKET REGULATORY INTELLIGENCE LANDSCAPE IN FINANCIAL SERVICES

CUBE's new product combines the best of CUBE into a simple solution for a growing market LONDON, April 9, 2025 /PRNewswire/ -- CUBE, a global leader in Automated Regulatory Intelligence (ARI) and Regulatory Change Management (RCM), has announced the launch of RegPlatform™ Intel, its latest purpo...

2025-04-09 14:00 1975
1234567 ... 49